杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/07/30 | 1,780 | 1,781 | 1,762 | 1,771 | -18 | -1% | 99,100 |
2021/07/29 | 1,797 | 1,805 | 1,780 | 1,789 | -9 | -0.5% | 84,800 |
2021/07/28 | 1,772 | 1,804 | 1,772 | 1,798 | +13 | +0.7% | 96,000 |
2021/07/27 | 1,801 | 1,803 | 1,777 | 1,785 | -35 | -1.9% | 138,200 |
2021/07/26 | 1,830 | 1,830 | 1,810 | 1,820 | +11 | +0.6% | 60,100 |
2021/07/21 | 1,842 | 1,842 | 1,803 | 1,809 | +7 | +0.4% | 90,700 |
2021/07/20 | 1,783 | 1,805 | 1,782 | 1,802 | +5 | +0.3% | 74,700 |
2021/07/19 | 1,785 | 1,799 | 1,779 | 1,797 | -5 | -0.3% | 62,900 |
2021/07/16 | 1,796 | 1,808 | 1,790 | 1,802 | -11 | -0.6% | 58,400 |
2021/07/15 | 1,829 | 1,839 | 1,806 | 1,813 | -12 | -0.7% | 99,300 |
2021/07/14 | 1,814 | 1,829 | 1,806 | 1,825 | +17 | +0.9% | 77,500 |
2021/07/13 | 1,809 | 1,812 | 1,796 | 1,808 | +4 | +0.2% | 85,300 |
2021/07/12 | 1,781 | 1,804 | 1,778 | 1,804 | +45 | +2.6% | 114,000 |
2021/07/09 | 1,727 | 1,765 | 1,725 | 1,759 | +6 | +0.3% | 188,500 |
2021/07/08 | 1,763 | 1,767 | 1,753 | 1,753 | -19 | -1.1% | 132,400 |
2021/07/07 | 1,788 | 1,788 | 1,765 | 1,772 | -19 | -1.1% | 168,100 |
2021/07/06 | 1,817 | 1,817 | 1,787 | 1,791 | -14 | -0.8% | 133,700 |
2021/07/05 | 1,830 | 1,834 | 1,805 | 1,805 | -25 | -1.4% | 91,000 |
2021/07/02 | 1,836 | 1,841 | 1,826 | 1,830 | -2 | -0.1% | 113,700 |
2021/07/01 | 1,823 | 1,833 | 1,818 | 1,832 | +20 | +1.1% | 140,400 |
2021/06/30 | 1,822 | 1,825 | 1,801 | 1,812 | +4 | +0.2% | 151,800 |
2021/06/29 | 1,801 | 1,814 | 1,789 | 1,808 | -9 | -0.5% | 155,300 |
2021/06/28 | 1,815 | 1,819 | 1,801 | 1,817 | +10 | +0.6% | 139,600 |
2021/06/25 | 1,813 | 1,817 | 1,794 | 1,807 | +14 | +0.8% | 286,000 |
2021/06/24 | 1,764 | 1,799 | 1,764 | 1,793 | +39 | +2.2% | 337,700 |
2021/06/23 | 1,753 | 1,771 | 1,750 | 1,754 | +6 | +0.3% | 184,100 |
2021/06/22 | 1,732 | 1,749 | 1,719 | 1,748 | +42 | +2.5% | 210,700 |
2021/06/21 | 1,705 | 1,719 | 1,699 | 1,706 | -24 | -1.4% | 173,300 |
2021/06/18 | 1,746 | 1,754 | 1,730 | 1,730 | -15 | -0.9% | 194,500 |
2021/06/17 | 1,760 | 1,763 | 1,740 | 1,745 | -6 | -0.3% | 104,300 |
2021/06/16 | 1,744 | 1,754 | 1,734 | 1,751 | +8 | +0.5% | 95,800 |
2021/06/15 | 1,746 | 1,748 | 1,728 | 1,743 | -13 | -0.7% | 171,800 |
2021/06/14 | 1,750 | 1,756 | 1,743 | 1,756 | +16 | +0.9% | 88,900 |
2021/06/11 | 1,750 | 1,753 | 1,731 | 1,740 | -5 | -0.3% | 168,000 |
2021/06/10 | 1,750 | 1,756 | 1,734 | 1,745 | +5 | +0.3% | 131,000 |
2021/06/09 | 1,733 | 1,748 | 1,727 | 1,740 | +10 | +0.6% | 110,000 |
2021/06/08 | 1,715 | 1,737 | 1,710 | 1,730 | +37 | +2.2% | 169,600 |
2021/06/07 | 1,685 | 1,703 | 1,682 | 1,693 | -10 | -0.6% | 183,400 |
2021/06/04 | 1,707 | 1,709 | 1,695 | 1,703 | +3 | +0.2% | 146,500 |
2021/06/03 | 1,665 | 1,702 | 1,663 | 1,700 | +27 | +1.6% | 260,900 |
2021/06/02 | 1,683 | 1,689 | 1,672 | 1,673 | -21 | -1.2% | 185,100 |
2021/06/01 | 1,710 | 1,712 | 1,685 | 1,694 | -15 | -0.9% | 143,000 |
2021/05/31 | 1,713 | 1,737 | 1,705 | 1,709 | -18 | -1% | 116,800 |
2021/05/28 | 1,705 | 1,728 | 1,701 | 1,727 | +37 | +2.2% | 128,400 |
2021/05/27 | 1,700 | 1,709 | 1,690 | 1,690 | -12 | -0.7% | 186,200 |
2021/05/26 | 1,733 | 1,734 | 1,702 | 1,702 | -32 | -1.8% | 131,900 |
2021/05/25 | 1,737 | 1,737 | 1,725 | 1,734 | -4 | -0.2% | 163,200 |
2021/05/24 | 1,730 | 1,746 | 1,725 | 1,738 | -3 | -0.2% | 121,000 |
2021/05/21 | 1,740 | 1,753 | 1,739 | 1,741 | -1 | -0.1% | 126,400 |
2021/05/20 | 1,753 | 1,765 | 1,742 | 1,742 | -16 | -0.9% | 91,900 |
901~
950
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 143,100円 | +3.2% | +4.5% | 3.63% | 16.44倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
サンバイオ | 162,700円 | - | - | 0.00% | - | 75.36倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
持田薬 | 301,500円 | +3.0% | +27.5% | 2.65% | 19.09倍 | 0.83倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ジーエヌアイ | 174,100円 | +21.7% | +999.9% | 0.00% | 7.25倍 | 2.40倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
栄研化 | 213,600円 | +0.4% | -8.4% | 2.48% | 27.42倍 | 1.55倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム